ESR1 and breast carcinoma: A study which analyzed ~2000 breast cancer patients showed that an OxPhos gene signature is significantly upregulated in human breast tumors (p < 1 × 10−20) relative to normal breast tissue, in both ER+ and ER- breast cancers [41].